{"disease":{"id":"early-cirrhosis","name":"early cirrhosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05740358","title":"Liver Cirrhosis Network Cohort Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1222,"lead_sponsor_name":"Northwestern University","has_results":false},{"nct_id":"NCT05832229","title":"Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":256,"lead_sponsor_name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","has_results":false},{"nct_id":"NCT03855956","title":"Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Kaleido Biosciences","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}